Supplementary Figure 3 . Survival plots of Immunity Score in different patient groups identified by low proliferation only and ER status in three datasets. Immune Score demonstrated insignificant prognosis in low proliferation group in AFFY1951 ER-negative (A) (p=0.59, n=142) or ER-positive (B) (p=0.9, n=757) , METABRIC ER-negative (C) (p=0.16, n=259) or ER-positive (D) (p=0.56, n=737), and TARGETSEQ ER-positive E) (p=0.69, n=123). Data was not shown for ER-negative and proliferation low group in TARGETSEQ dataset due to the low number of patients (n=18 with only 1 istrong) in this group. Figure 4 . Comparison of heatmaps of iRDM (A) and PAM50 (B) in AFFY1951 breast cancer training dataset and validation of iRDM subtypes in three independent test datasets METABRIC (C), TCGA (D), and TARGETSEQ (E). Subtypes are shown by color-coded bars: Basal-like (Red), HER2E (Hot Pink), Immuno (Yellow), Luminal A (Dark Blue), Luminal B (Sky Blue), Normal-like (Green), Mixed (Grey, not a subtype but a collection of samples with subtype confidence less than 0.95). Immuno group were observed across all four independent datasets using different platforms.
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Supplementary Figure 5 . Heatmap of the Affy1951 iRDM Immunity-enhanced group samples only (N=342) with samples ordered by PAM50 subtypes. PAM50 subtypes were color-coded. Gene clusters in the heatmap demonstrated that the 17 immunity genes were highly expressed in all PAM50 subtypes.
Basal HER2E LumA
LumB Normal Mixed
PAM50
Immunity-enhanced group iRDM Supplementary Figure 6 . Heatmap of the Claudin-low (CLOW) signature genes in the Immunity-enhanced subtype. Expression of the top 80 Claudin-low signature genes (Prat et al, BCR 2010)(fix this reference) identified less than 1/3 of Immunity-enhanced subtype samples as CLOW subtype (black color bar) in each of the three datasets (A-C). Not-CLOW (yellow color bar) and CLOW groups within the Immunity-enhanced subtype were highly correlated and had no difference in survival prognosis in AFFY1951 (D) (p=0.4, n=342), METABRIC (E) (p=0.15, n=323), TCGA (F) (p=0.81, n=151).
AFFY1951
METABRIC TCGA 
ER genes (14) Basal genes (11) Reference Genes (6) Immunity genes(17) Invasion genes(2) Prolif genes(19)
Supplemental 
